Cambridge Investment Research Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Buy |
|
|||||
|
2025
Q1 | $304K | Sell |
|
|||||
|
2024
Q4 | $537K | Sell |
|
|||||
|
2024
Q3 | $508K | Sell |
|
|||||
|
2024
Q2 | $675K | Sell |
|
|||||
|
2024
Q1 | $3.15M | Buy |
|
|||||
|
2023
Q4 | $858K | Sell |
|
|||||
|
2023
Q3 | $1.03M | Sell |
|
|||||
|
2023
Q2 | $1.09M | Sell |
|
|||||
|
2023
Q1 | $1.09M | Sell |
|
|||||
|
2022
Q4 | $1.38M | Buy |
|
|||||
|
2022
Q3 | $913K | Sell |
|
|||||
|
2022
Q2 | $1.27M | Sell |
|
|||||
|
2022
Q1 | $2.32M | Sell |
|
|||||
|
2021
Q4 | $2.98M | Sell |
|
|||||
|
2021
Q3 | $3.3M | Buy |
|
|||||
|
2021
Q2 | $1.47M | Sell |
|
|||||
|
2021
Q1 | $1.33M | Buy |
|
|||||
|
2020
Q4 | $1.18M | Buy |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $810K | Sell |
|
|||||
|
2020
Q1 | $574K | Buy |
|
|||||
|
2019
Q4 | $537K | Buy |
|
|||||
|
2019
Q3 | $398K | Sell |
|
|||||
|
2019
Q2 | $356K | Buy |
|
|||||
|
2019
Q1 | $282K | Sell |
|
|||||
|
2018
Q4 | $324K | Buy |
|
|||||
|
2018
Q3 | $361K | Sell |
|
|||||
|
2018
Q2 | $408K | Buy |
|
|||||
|
2018
Q1 | $360K | Sell |
|
|||||
|
2017
Q4 | $416K | Buy |
|
|||||
|
2017
Q3 | $374K | Buy |
|
|||||
|
2017
Q2 | $319K | Buy |
|
|||||
|
2017
Q1 | $210K | Buy |
|
|||||
|
2016
Q4 | $215K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $205K | Buy |
|